Panacea Pharma Projects

Douglas, United Kingdom Founded: 2008 • Age: 18 yrs Acquired By Ergomed
Pharmacovigilance and regulatory services for drugs and devices are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Panacea Pharma Projects

Panacea Pharma Projects is a company based in Douglas (United Kingdom) founded in 2008 was acquired by Ergomed in October 2023. Panacea Pharma Projects operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

  • Headquarter Douglas, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Ergomed

    (Oct 10, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Panacea Pharma Projects

Investors in Panacea Pharma Projects

Panacea Pharma Projects has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.

All
Institutional
Investor Description Founded Year Domain Location
Clinical CRO services for oncology and rare diseases are provided.
Founded Year Domain Location

Investments & Acquisitions by Panacea Pharma Projects

Investments

Financial Statements - Panacea Pharma Projects

Panacea Pharma Projects Comparisons

+
Add Comparison
Available on Premium

Competitors of Panacea Pharma Projects

Panacea Pharma Projects operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
domain founded_year HQ Location
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
domain founded_year HQ Location
CRO specializing in regulatory affairs and pharmacovigilance
domain founded_year HQ Location
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
domain founded_year HQ Location
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
domain founded_year HQ Location
Provider of regulatory compliance and validation support to life science industries

Latest news on Panacea Pharma Projects

Frequently Asked Questions about Panacea Pharma Projects

Panacea Pharma Projects was founded in 2008.

Panacea Pharma Projects is headquartered in Douglas, United Kingdom.

Panacea offers pharmacovigilance services and a host of regulatory affairs services at the clinical trial, marketing authorisation and post-authorisation stages for drugs and medical devices. The companys service portfolio includes supply of EU Qualified Person for Pharmacovigilance (QPPV), Preparation and Maintenance of Pharmacovigilance System Master File (PSMF) and Risk Management Plans (RMP), Medical Information provisions and ICSR ( Individual case safety report ) submission via EVWEB, and the setup and maintenance of Safety Data Exchange Agreements (SDEA). The company was shortlisted for the Industry Partner of the Year at The Global Generics and Biosimilars Awards 2016, which recognises the achievements of CROs and service providers to the generics and biosimilar industries.

Panacea Pharma Projects's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.

Panacea Pharma Projects has 1 investor. Key investors include Ergomed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available